Search results
Left in limbo: When pharma halts rare disease research
Pharmaceutical Technology· 22 hours ago“The cost of reagents needed to make a gene therapy product is high, but we hope that this may come...
“The cost of reagents needed to make a gene therapy product is high, but we hope that this may come...